[Against continuing oral contraceptives up to age 50].
Haramburu
F
F
Centre régional de pharmacovigilance, département de pharmacologie U657, hôpital Pellegrin, CHU de Bordeaux, 1, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France. francoise.haramburu@u-bordeaux2.fr
D000367:Age Factors; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000453:epidemiology; D003276:Contraceptives, Oral / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012307:Risk Factors; D013923:Thromboembolism / Q000139:chemically induced* / Q000453:epidemiology
D003276:Contraceptives, Oral